To:
`
`Subject:
`
`Sent:
`
`Sent As:
`
`Attachments:
`
`PANASONIC HEALTHCARE CORPORATION OF NORT ETC. (ptodocket@arelaw.com)
`
`U.S. TRADEMARK APPLICATION NO. 86138643 - DISCOVERY POWERED BY PRECISION -
`55210-0765
`
`9/19/2014 11:21:15 AM
`
`ECOM101@USPTO.GOV
`
`Attachment - 1
`Attachment - 2
`Attachment - 3
`Attachment - 4
`Attachment - 5
`Attachment - 6
`Attachment - 7
`Attachment - 8
`Attachment - 9
`Attachment - 10
`Attachment - 11
`Attachment - 12
`Attachment - 13
`Attachment - 14
`Attachment - 15
`Attachment - 16
`Attachment - 17
`Attachment - 18
`Attachment - 19
`Attachment - 20
`Attachment - 21
`Attachment - 22
`
`UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO)
`OFFICE ACTION (OFFICIAL LETTER) ABOUT APPLICANT’S TRADEMARK APPLICATION
`
`U.S. APPLICATION SERIAL NO. (cid:160) 86138643
`
`(cid:160) (cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`(cid:160) (cid:160) (cid:160)
`
`(cid:160)M
`
`ARK: DISCOVERY POWERED BY PRECISION
`
`CORRESPONDENT ADDRESS:
`(cid:160)(cid:160)
`(cid:160)(cid:160) (cid:160) (cid:160) HOLLY PEKOWSKY, ESQ.
`(cid:160)(cid:160)
`(cid:160)(cid:160) (cid:160) (cid:160) AMSTER ROTHSTEIN & EBENSTEIN LLP
`(cid:160) (cid:160) (cid:160)(cid:160)(cid:160)(cid:160) 90 PARK AVE
`(cid:160) (cid:160) (cid:160)(cid:160) (cid:160) (cid:160) NEW YORK, NY 10016-1301
`(cid:160)(cid:160)(cid:160)(cid:160)
`APPLICANT: PANASONIC HEALTHCARE CORPORATION OF
`NORT ETC.
`
`*86138643*
`
`CLICK HERE TO RESPOND TO THIS LETTER:
`http://www.uspto.gov/trademarks/teas/response_forms.jsp
`
`VIEW YOUR APPLICATION FILE
`
`(cid:160) (cid:160)(cid:160)
`CORRESPONDENT’S REFERENCE/DOCKET NO :(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`CORRESPONDENT E-MAIL ADDRESS:(cid:160)(cid:160)(cid:160)
`
`(cid:160) 55210-0765
`
`(cid:160)(cid:160)(cid:160)
`
`(cid:160)(cid:160)(cid:160)(cid:160) ptodocket@arelaw.com
`
`NON-FINAL OFFICE ACTION
`
`STRICT DEADLINE TO RESPOND TO THIS LETTER
`
`(cid:160)
`(cid:160)
`(cid:160)
`(cid:160)
`

`

`TO AVOID ABANDONMENT OF APPLICANT’S TRADEMARK APPLICATION, THE USPTO MUST RECEIVE APPLICANT’S
`COMPLETE RESPONSE TO THIS LETTER WITHIN 6 MONTHS OF THE ISSUE/MAILING DATE BELOW.
`
`(cid:160)I
`
`SSUE/MAILING DATE: 9/19/2014
`
`(cid:160)T
`
`he Office of the Deputy Commissioner for Trademark Examination Policy accepted a Letter of Protest received in connection with this
`application.(cid:160) The evidence presented in the letter was forwarded to the trademark examining attorney for consideration.(cid:160) See TMEP §1715.
`
`(cid:160)B
`
`ased upon this evidence, the trademark examining attorney is taking further action, as specified below.(cid:160) See TMEP §1715.02(b).
`
`In addition to the refusal in this Office action, all refusals and requirements in the Office action dated August 30, 2014, are herein incorporated
`by reference.(cid:160) Therefore, a proper response to this Office action must address each issue raised in the preceding Office action as well as in this
`Office action.
`
`(cid:160)1
`
`.(cid:160) Refusal – Section 2(d) Refusal to Register – Likelihood of Confusion:
`Registration of the applied-for mark is refused because of a likelihood of confusion with the mark in U.S. Registration No. 2563114.(cid:160) Trademark
`Act Section 2(d), 15 U.S.C. §1052(d); see TMEP §§1207.01 et seq.(cid:160) See the enclosed registration.
`
`(cid:160)T
`
`rademark Act Section 2(d) bars registration of an applied-for mark that so resembles a registered mark that it is likely a potential consumer
`would be confused, mistaken, or deceived as to the source of the goods and/or services of the applicant and registrant.(cid:160) See 15 U.S.C. §1052(d).(cid:160)
`A determination of likelihood of confusion under Section 2(d) is made on a case-by case basis and the factors set forth in In re E. I. du Pont de
`Nemours & Co., 476 F.2d 1357, 177 USPQ 563 (C.C.P.A. 1973) aid in this determination.(cid:160) Citigroup Inc. v. Capital City Bank Grp., Inc., 637
`F.3d 1344, 1349, 98 USPQ2d 1253, 1256 (Fed. Cir. 2011) (citing On-Line Careline, Inc. v. Am. Online, Inc., 229 F.3d 1080, 1085, 56 USPQ2d
`1471, 1474 (Fed. Cir. 2000)).(cid:160) Not all the du Pont factors, however, are necessarily relevant or of equal weight, and any one of the factors may
`control in a given case, depending upon the evidence of record.(cid:160) Citigroup Inc. v. Capital City Bank Grp., Inc., 637 F.3d at 1355, 98 USPQ2d at
`1260; In re Majestic Distilling Co., 315 F.3d 1311, 1315, 65 USPQ2d 1201, 1204 (Fed. Cir. 2003); see In re E. I. du Pont de Nemours & Co., 476
`F.2d at 1361-62, 177 USPQ at 567.
`
`(cid:160)I
`
`n this case, the following factors are the most relevant:(cid:160) similarity of the marks, similarity and nature of the goods and/or services, and
`similarity of the trade channels of the goods and/or services.(cid:160) See In re Viterra Inc., 671 F.3d 1358, 1361-62, 101 USPQ2d 1905, 1908 (Fed. Cir.
`2012); In re Dakin’s Miniatures Inc. , 59 USPQ2d 1593, 1595-96 (TTAB 1999); TMEP §§1207.01 et seq.
`
`(cid:160)T
`
`he overriding concern is not only to prevent buyer confusion as to the source of the goods and/or services, but to protect the registrant from
`adverse commercial impact due to use of a similar mark by a newcomer.(cid:160) See In re Shell Oil Co., 992 F.2d 1204, 1208, 26 USPQ2d 1687, 1690
`(Fed. Cir. 1993).(cid:160) Therefore, any doubt regarding a likelihood of confusion determination is resolved in favor of the registrant.(cid:160) TMEP
`§1207.01(d)(i); see Hewlett-Packard Co. v. Packard Press, Inc., 281 F.3d 1261, 1265, 62 USPQ2d 1001, 1003 (Fed. Cir. 2002); In re Hyper
`Shoppes (Ohio), Inc., 837 F.2d 463, 464-65, 6 USPQ2d 1025, 1026 (Fed. Cir. 1988).
`
`(cid:160)C
`
`omparison of the Marks:
`Marks are compared in their entireties for similarities in appearance, sound, connotation, and commercial impression.(cid:160) In re Viterra Inc., 671 F.3d
`1358, 1362, 101 USPQ2d 1905, 1908 (Fed. Cir. 2012) (quoting In re E. I. du Pont de Nemours & Co., 476 F.2d 1357, 1361, 177 USPQ 563, 567
`(C.C.P.A. 1973)); TMEP §1207.01(b)-(b)(v).(cid:160) Similarity in any one of these elements may be sufficient to find the marks confusingly similar.(cid:160) In
`re White Swan Ltd., 8 USPQ2d 1534, 1535 (TTAB 1988); see In re 1st USA Realty Prof’ls, Inc., 84 USPQ2d 1581, 1586 (TTAB 2007); TMEP
`§1207.01(b).
`
`(cid:160)T
`
`he applicant’s mark is DISCOVERY POWERED BY PRECISION. (cid:160) The registrant’s mark is PRECISION. (cid:160) The applicant’s mark is similar to
`the registrant’s mark because they both include the identical wording PRECISION.
`
`(cid:160)M
`
`arks may be confusingly similar in appearance where similar terms or phrases or similar parts of terms or phrases appear in the compared
`marks and create a similar overall commercial impression.(cid:160) See Crocker Nat’l Bank v. Canadian Imperial Bank of Commerce, 228 USPQ 689,
`690-91 (TTAB 1986), aff’d sub nom. Canadian Imperial Bank of Commerce v. Wells Fargo Bank, Nat’l Ass’n , 811 F.2d 1490, 1495, 1
`USPQ2d 1813, 1817 (Fed. Cir. 1987) (finding COMMCASH and COMMUNICASH confusingly similar); In re Corning Glass Works, 229
`USPQ 65, 66 (TTAB 1985) (finding CONFIRM and CONFIRMCELLS confusingly similar); In re Pellerin Milnor Corp., 221 USPQ 558, 560
`(TTAB 1983) (finding MILTRON and MILLTRONICS confusingly similar); TMEP §1207.01(b)(ii)-(iii).
`
`(cid:160)A
`
`dditionally, adding a term to a registered mark generally does not obviate the similarity between the compared marks, as in the present case,
`nor does it overcome a likelihood of confusion under Section 2(d).(cid:160) See Coca-Cola Bottling Co. v. Jos. E. Seagram & Sons, Inc., 526 F.2d 556,
`557, 188 USPQ 105, 106 (C.C.P.A. 1975) (finding BENGAL and BENGAL LANCER and design confusingly similar); In re Toshiba Med. Sys.
`Corp., 91 USPQ2d 1266, 1269 (TTAB 2009) (finding TITAN and VANTAGE TITAN confusingly similar); In re El Torito Rests., Inc., 9
`USPQ2d 2002, 2004 (TTAB 1988) (finding MACHO and MACHO COMBOS confusingly similar); TMEP §1207.01(b)(iii).(cid:160) In the present
`case, the marks are identical in part.
`
`(cid:160)
`

`

`(cid:160)A
`
`ccordingly, because the applicant’s mark and the registrant’s mark both include the identical wording PRECISION, the overall commercial
`impression of the marks is highly similar.
`
`(cid:160)C
`
`omparison of the Goods/Services:
`The goods and/or services of the parties need not be identical or even competitive to find a likelihood of confusion.(cid:160) See On-line Careline Inc. v.
`Am. Online Inc., 229 F.3d 1080, 1086, 56 USPQ2d 1471, 1475 (Fed. Cir. 2000); Recot, Inc. v. Becton, 214 F.3d 1322, 1329, 54 USPQ2d 1894,
`1898 (Fed. Cir. 2000) (“[E]ven if the goods in question are different from, and thus not related to, one another in kind, the same goods can be
`
`related in the mind of the consuming public as to the origin of the goods.”); TMEP §1207.01(a)(i). (cid:160)(cid:160)
`
`The respective goods and/or services need only be “related in some manner and/or if the circumstances surrounding their marketing [be] such
`that they could give rise to the mistaken belief that [the goods and/or services] emanate from the same source.” (cid:160) Coach Servs., Inc. v. Triumph
`Learning LLC, 668 F.3d 1356, 1369, 101 USPQ2d 1713, 1722 (Fed. Cir. 2012) (quoting 7-Eleven Inc. v. Wechsler, 83 USPQ2d 1715, 1724
`(TTAB 2007)); Gen. Mills Inc. v. Fage Dairy Processing Indus. SA, 100 USPQ2d 1584, 1597 (TTAB 2011); TMEP §1207.01(a)(i).
`
`(cid:160)T
`
`he applicant’s goods are, “A central laboratory control and monitoring solution, namely, a system comprised of software and computer
`peripherals for use in monitoring, storage, control, and analysis of laboratory data and laboratory protocols, and the transmission thereof to a
`mobile device; laboratory monitoring system, namely, application software for displaying data on mobile devices including smart phones, tablets
`and computers; CO2 incubators for laboratory use; incubation, oxygen and carbon dioxide chambers for laboratory use; laboratory furniture,
`namely, clean benches for laboratory use; laboratory furniture, namely, biological safety cabinets for laboratory use for preventing biohazards;
`dental CCD (charge coupled device) sensor systems comprised of CCD sensors and monitors; DNA analysis apparatus, namely, scientific
`apparatus for measuring relative DNA; Sterilization equipment for use in a research environment, namely, steam sterilizers for laboratory use”
`and “Surgical apparatus and instruments for medical, dental and veterinary use; artificial limbs, eyes and teeth; orthopedic articles, namely,
`orthopedic instruments; suture materials; medical semiconductor laser treatment devices, namely, lasers for the cosmetic treatment of the face
`and skin; ultrasonic medical diagnostic apparatus; hearing aids; electronic blood pressure meters; blood pressure management systems comprised
`of blood pressure measuring apparatus; electronic clinical thermometers; electric therapeutic beds for medical purposes; low frequency electric
`therapy apparatus; high frequency electric therapy apparatus; electric air mattresses for prevention of bedsore for medical purposes; electric
`inhalers for medical purposes; electric heating pads for medical use; incontinence sheets for medical use; electrically heated carpets for medical
`use; medical products, namely, electric sensors for blood sugar level measurement; medical products, namely, electric sensors for blood lactate
`level measurement; diagnostic apparatus and instruments for medical purposes for diagnosing diabetes, heart attack, blood pressure levels.
`cholesterol levels, arteriosclerosis, IVF and fertility issues; testing apparatus and instruments for medical purposes, namely, ergometers for
`medical testing purposes; electric blankets for medical purposes; oral irrigators for medical purposes; therapeutic beds for medical use; ocular
`movement testers; dental intraoral cameras; CO2 incubators for medical use; cooled incubators for medical use; plant growth chambers for
`medical use; blood pressure monitoring apparatus; Furniture especially made for medical purposes in the nature of clean benches for medical
`purposes and biohazard safety cabinets for medical use for preventing biohazards; medical diagnostic apparatus for analysis of gene expression;
`body rehabilitation apparatus for medical purposes; Sterilization equipment for use in a medical environment, namely, medical sterilizers;
`devices used in cell therapy and regenerative medicine, namely, cell culture chambers; vaccine storage and manufacturing devices, namely,
`refrigerators, freezers and refrigerator/freezer combinations.”
`
`(cid:160)T
`
`he registrant’s goods are, “laboratory apparatus, namely water baths, incubators, refrigerators, and ovens [ hot plates ].”
`
`(cid:160)T
`
`he applicant’s goods are related to the registrant’s goods because these types of goods travel through the same channels of trade to the same
`classes of purchasers.(cid:160) Additionally, the registrant’s goods are written broadly enough to encompass the applicant’s goods.
`
`(cid:160)W
`
`ith respect to applicant’s and registrant’s goods and/or services, the question of likelihood of confusion is determined based on the
`description of the goods and/or services stated in the application and registration at issue, not on extrinsic evidence of actual use.(cid:160) See, e.g.,
`Coach Servs., Inc. v. Triumph Learning LLC, 668 F.3d 1356, 1369-70, 101 USPQ2d 1713, 1722 (Fed. Cir. 2012); Octocom Sys. Inc. v. Hous.
`
`Computers Servs. Inc., 918 F.2d 937, 942, 16 USPQ2d 1783, 1787 (Fed. Cir. 1990).(cid:160)(cid:160)
`
`Absent restrictions in an application and/or registration, the identified goods and/or services are “presumed to travel in the same channels of
`trade to the same class of purchasers.” (cid:160) In re Viterra Inc., 671 F.3d 1358, 1362, 101 USPQ2d 1905, 1908 (Fed. Cir. 2012) (quoting Hewlett-
`Packard Co. v. Packard Press, Inc., 281 F.3d 1261, 1268, 62 USPQ2d 1001, 1005 (Fed. Cir. 2002)).(cid:160) Additionally, unrestricted and broad
`identifications are presumed to encompass all goods and/or services of the type described.(cid:160) See In re Jump Designs, LLC, 80 USPQ2d 1370, 1374
`
`(TTAB 2006) (citing In re Elbaum, 211 USPQ 639, 640 (TTAB 1981)); In re Linkvest S.A., 24 USPQ2d 1716, 1716 (TTAB 1992).(cid:160)(cid:160)
`
`In this case, the identification set forth in the application and registration(s) has no restrictions as to nature, type, channels of trade, or classes of
`purchasers.(cid:160) Therefore, it is presumed that these goods and/or services travel in all normal channels of trade, and are available to the same class
`of purchasers.(cid:160) Further, the registration use(s) broad wording to describe the goods and/or services and this wording is presumed to encompass all
`goods and/or services of the type described, including those in applicant’s more narrow identification.
`
`(cid:160)F
`
`urther, the trademark examining attorney has attached evidence from the USPTO’s X-Search database consisting of a number of third-party
`
`

`

`marks registered for use in connection with the same or similar goods and/or services as those of both applicant and registrant in this case.(cid:160) This
`evidence shows that the goods and/or services listed therein, namely, incubators, laboratory furniture, laboratory ovens, blood pressure monitors,
`medical diagnostic apparatus, and steam sterilizers for laboratory use are of a kind that may emanate from a single source under a single mark.(cid:160)
`See In re Anderson, 101 USPQ2d 1912, 1919 (TTAB 2012); In re Albert Trostel & Sons Co., 29 USPQ2d 1783, 1785-86 (TTAB 1993); In re
`Mucky Duck Mustard Co., 6 USPQ2d 1467, 1470 n.6 (TTAB 1988); TMEP §1207.01(d)(iii).
`
`(cid:160)A
`
`ccordingly, because the marks are similar and the goods are overlapping and closely related, confusion as to source is likely and registration is
`refused under Section 2(d) of the Trademark Act.
`
`(cid:160)A
`
`lthough applicant’s mark has been refused registration, applicant may respond to the refusal(s) by submitting evidence and arguments in
`support of registration.
`
`(cid:160)2
`
`.(cid:160) Advisory – Response Guidelines:
`For this application to proceed toward registration, applicant must explicitly address each refusal and/or requirement raised in this Office action.(cid:160)
`If the action includes a refusal, applicant may provide arguments and/or evidence as to why the refusal should be withdrawn and the mark should
`register.(cid:160) Applicant may also have other options for responding to a refusal and should consider such options carefully.(cid:160) To respond to
`requirements and certain refusal response options, applicant should set forth in writing the required changes or statements.
`
`(cid:160)R
`
`If an applicant is not
`esponses to Office actions must be properly signed. (cid:160) See 37 C.F.R. §§2.62(b), 2.193(e)(2); TMEP §§712, 712.01.(cid:160)
`represented by an attorney, the response must be signed by the individual applicant or someone with legal authority to bind a juristic applicant
`(e.g., a corporate officer or general partner).(cid:160) See 37 C.F.R. §2.193(e)(2)(ii); TMEP §§611.03(b), 611.06(b)-(h), 712.01.(cid:160) In the case of joint
`applicants, all must sign.(cid:160) 37 C.F.R. §2.193(e)(2)(ii); TMEP §611.06(a).(cid:160) If an applicant is represented by an attorney authorized to practice
`
`before the USPTO, the attorney must sign the response.(cid:160) 37 C.F.R. §2.193(e)(2)(i); TMEP §§611.03(b), 712.01.(cid:160)(cid:160)
`3.(cid:160) Advisory – Assistance:
`If applicant has questions regarding this Office action, please telephone or e-mail the assigned trademark examining attorney.(cid:160) All relevant e-
`mail communications will be placed in the official application record; however, an e-mail communication will not be accepted as a response to
`this Office action and will not extend the deadline for filing a proper response.(cid:160) See 37 C.F.R. §2.191; TMEP §§304.01-.02, 709.04-.05.(cid:160) Further,
`although the trademark examining attorney may provide additional explanation pertaining to the refusal(s) and/or requirement(s) in this Office
`action, the trademark examining attorney may not provide legal advice or statements about applicant’s rights. (cid:160) See TMEP §§705.02, 709.06.
`
`/Colleen Dombrow/
`Trademark Attorney
`Law Office 101
`Direct Dial: 571-272-8262
`Facsimile: 571-273-9101
`colleen.dombrow@uspto.gov
`
`(cid:160)T
`
`O RESPOND TO THIS LETTER: (cid:160) Go to http://www.uspto.gov/trademarks/teas/response_forms.jsp. (cid:160) Please wait 48-72 hours from the
`issue/mailing date before using the Trademark Electronic Application System (TEAS), to allow for necessary system updates of the application.(cid:160)
`For technical assistance with online forms, e-mail TEAS@uspto.gov.(cid:160) For questions about the Office action itself, please contact the assigned
`trademark examining attorney.(cid:160) E-mail communications will not be accepted as responses to Office actions; therefore, do not respond to
`this Office action by e-mail.
`
`(cid:160)A
`
`ll informal e-mail communications relevant to this application will be placed in the official application record.
`
`(cid:160)W
`
`HO MUST SIGN THE RESPONSE:(cid:160) It must be personally signed by an individual applicant or someone with legal authority to bind an
`applicant (i.e., a corporate officer, a general partner, all joint applicants).(cid:160) If an applicant is represented by an attorney, the attorney must sign the
`
`response.(cid:160)(cid:160)
`PERIODICALLY CHECK THE STATUS OF THE APPLICATION: (cid:160) To ensure that applicant does not miss crucial deadlines or official
`notices, check the status of the application every three to four months using the Trademark Status and Document Retrieval (TSDR) system at
`http://tsdr.uspto.gov/. (cid:160) Please keep a copy of the TSDR status screen. (cid:160) If the status shows no change for more than six months, contact the
`Trademark Assistance Center by e-mail at TrademarkAssistanceCenter@uspto.gov or call 1-800-786-9199. (cid:160) For more information on checking
`status, see http://www.uspto.gov/trademarks/process/status/.
`
`(cid:160)T
`
`O UPDATE CORRESPONDENCE/E-MAIL ADDRESS:(cid:160) Use the TEAS form at http://www.uspto.gov/trademarks/teas/correspondence.jsp.
`
`(cid:160)
`(cid:160)(cid:160)
`

`

`Print: Sep 19, 2014
`
`78089063
`
`DESIGN MARK
`
`Serial Number
`TEOESOEB
`
`Status
`REGISTERED AND RENEWED
`
`Word Mark
`PRECISICN
`
`Standard Character Merit
`No
`
`Registration Number
`2563114
`
`Date Registered
`2DD2xD4x23
`
`Type of Marin
`TRADEMARK
`
`Register
`PRINCIPAL
`
`Mark Drawing Code
`[1] TYPED DRAWING
`
`Owner
`THERNC EISRER SCIENTIEIC [ASHEVILLE] LLC LIMITED LIABILITY CCNPANY
`DELPLWPLRE 81 WYI‘-'13-‘IN STREET W.i5LLTI-LN‘-I MASSACHUSETTS D2454
`
`Goodsfservioes
`Class Status —— ACTIVE.
`
`IC 009.
`
`Us
`
`U21 U23 U26 U36 038.
`
`G R S:
`
`incubators, refrigerators,
`laboratory apparatus, namely water bathe,
`and ovens [ hot plates ]. First Use:
`lSTTfO5/ll. First Use In
`Commerce:
`l9T7fU5fll.
`
`Filing Date
`2000fU6fl2
`
`Examining Attorney
`MADDEN.ANNE
`
`Attorney of Record
`John H. Weber
`
`

`

`

`

`Pfini:Sep19,2fl14
`
`79692299
`
`DESIGN MARK
`
`Serial Number
`16692299
`
`Status
`REGISTERED
`
`Word Mark
`LABRECYCLERS INc.
`
`Standard Character Merit
`No
`
`Registration Number
`3119921
`
`Date Registered
`2010104121
`
`Type of Marin
`TRADEMARK
`
`Register
`PRINCIPAL
`
`Mark Drawing Code
`[3] DESIGN PLUS woRDS, LETTERS ANDx0R NDNEERS
`
`Dvmer
`Lab Recyclers, Inc. CORPORATION MARYLAND T421 Lindbergh Drive
`Gaithersburg MARYLAND 2U8T9
`
`Goodsfserviees
`Class Status —— ACTIVE.
`
`IC 009.
`
`Us
`
`U21 U23 U26 U36 038.
`
`G R 8:
`
`Laboratory furnishings, namely, casework, phenolic resin and epoxy
`resin countertops, reagent racking, wall shelve units and laboratory
`sink assemblies;
`laboratory equipment, namely, centrifuges.
`incubators, biological safety cabinets, autoclaves, namely, steam
`sterilizers for laboratory use, and ULT freezers; and laboratory
`instrumentation, namely, spectrophotometers, microplate readers, high
`performance liquid chromatography [HPLC],
`liquid handling robotics,
`DNA sequencers, and particle sizers. First Use:
`l998HOlfUl. First
`Use In Commerce:
`l998fOlfOl.
`
`Disclaimer Statement
`NO CLAIM IS MADE TO THE EXCLUSIVE RIGHT TO USE "INC." APART FROM THE
`MARK AS SHOWN.
`
`Colors Claimed
`Color is not claimed as a feature of the mark.
`
`.1.
`
`

`

`Print: Sep 19, 2014-
`
`76892299
`
`Filing Date
`2008H08H22
`
`Examining Attorney
`LEE, DOUGLAS
`
`Attorney of Record
`Karen N. Shapiro
`
`

`

`
`
`

`

`Pfini:Sep19,2fl14
`
`T7331flT4
`
`DESIGN MARK
`
`Serial Number
`TT33l8T4
`
`Status
`SECTIoN e & 15—ACCEPTED AND ACRNCWLEDGED
`
`Word Mark
`THE EINDING SITE
`
`Standard Character Merit
`No
`
`Registration Number
`3419719
`
`Date Registered
`2DDSxDSxD5
`
`Type of Marin
`TRADEMARK
`
`Register
`PRINCIPAL
`
`Mark Drawing Code
`[3] DESIGN PLDS WCRDS, LETTERS ANDxoR NDNEERS
`
`Dvmer
`THE EINDING SITE GRCDP, LTD. CCRPCRATICN UNITED KINGDOM S Calthorpe
`Road Birmingham UNITED KINGDOM Bl5lQT
`
`Goodsfserviees
`Class Status -- ACTIVE.
`
`IC 010.
`
`US
`
`U26 U39 044.
`
`G & 3: Medical
`
`treatment and
`diagnostic apparatus and instruments for the diagnosis,
`cure of diseases in humans, namely, multiple myeloma,
`lymphooytio
`neoplasms. Waldenstrom‘s macroglcbulinemia, amyloidosis.
`light chain
`deposition diseases and connective tissues diseases, namely, systemic
`lupus erythematosus; apparatus for blood, urine and serum analysis;
`apparatus for clinical diagnosis; apparatus used in implementing
`diagnostic tests designed to detect abnormalities in blood, serum and
`urine, namely, automated Clinical analyzers based on Colorimetric and
`turbidmetric measurements, diluents, reagents, Calibrators, and
`control serum; and medical diagnostic apparatus and analytical
`apparatus for medical purposes. First Use:
`IQBQIOOHOO. First Use In
`Commerce:
`IBSBXOOXOO.
`
`Goodsiserviees
`Class Status —— ACTIVE.
`
`IC 001.
`
`DS
`
`CD1 CD5 D06 D10 O26 046.
`
`G & S:
`
`Diagnostic kits comprised of diagnostic reagents for laboratory use,
`
`.1.
`
`

`

`Pfini:Sep19,2fl14
`
`T7331flT4
`
`reagent plates, buffered solutions, diluent solutions,
`calibrators,
`and serum; Reagents, diagnostic reagents, biological reagents,
`histology reagents, enzyme radioimmunoassay reagents,
`immunoassay
`reagents, antigen substrates, and antibodies for scientific research
`use: and test kits comprised of reagents, buffers, calibrators,
`diluents, antibodies, antigen substrates, conjugates, stopping
`solutions, antisera andfor dropper bottles for scientific and research
`use using blood, body fluids, body tissues or extracts thereof;
`Biochemicals, namely, monoclonal antibodies for in vitro scientific or
`research use; Chemicals, namely, buffer and standard solutions used in
`analytical chemistry; Diagnostic preparations for scientific or
`research use; Diagnostic preparations for scientific use; Diagnostic
`preparations used in science; Diagnostic reagents for in vitro use in
`biochemistry, clinical chemistry and microbiology; Reagents for
`chemical analyses; Reagents for research purposes; Reagents for
`scientific or medical research use; Reagents for use in scientific
`apparatus for chemical or biological analysis; electrophoresis gels
`other than for medical or veterinary purposes. First Use: 1989fOOfOO.
`First Use In Commerce:
`l989/O0/00.
`
`Goodsfservices
`Class Status —— ACTIVE.
`
`Ic 005.
`
`Us
`
`O06 O18 044 046 051 052.
`
`G & a:
`
`Calibrating solutions, diluents, control samples, reagents,
`antibodies, antigen substrates, conjugates, stopping solutions,
`immunofluorescence reagents, histology reagents, enzyme immunoassay
`reagents and general purpose reagents for medical and veterinary
`diagnostic and clinical use: and diagnostic and immunological test
`kits consisting of reagents, controls, buffers, calibrators, diluents,
`antibodies, antigen substrates, conjugates, stopping solutions,
`antisera andfor dropper bottles, all for use in measuring the
`concentration of proteins, antibodies, antigens and other substances
`in blood, other body fluids and body tissues, or extracts thereof, for
`use in the diagnosis,
`treatment, cure, prevention or mitigation of
`diseases and other conditions in humans and animals; biological and
`chemical preparations and reagents for medical or veterinary use;
`Clinical medical reagents; Diagnostic preparations for clinical or
`medical laboratory use; Diagnostic preparations for medical and
`veterinary use; Diagnostic reagents for medicinal use; Medical
`diagnostic reagents: Medical diagnostic reagents and assays for
`testing of body fluids; Reagents and media for medical and veterinary
`diagnostic purposes; Reagents for medical use; medical diagnostic kits
`for use in electrophoresis,
`immunology and serolOgY. consisting
`primarily of extracts from blood or body fluids; control solutions
`indicative of a positive result for medical use; buffer solutions for
`diluting samples andfor reagents for medical use; reagents, blood
`reagents; electrophoretic gels for medical purposes; protein stain,
`for visualizing results, for medical purposes; antisera for
`precipitating specific proteins, for medical purposes; fixative for
`precipitating proteins, for medical purposes;
`templates for
`controlling the application of samples andfor antisera, for medical
`purposes; blotting paper and blotting tissues for removing excess
`
`Q.
`
`

`

`Pfint:Sep19,2fl14
`
`T7331flT4
`
`liquid for gels, for medical purposes. First Use:
`Use In Commerce: 1989fOUfUU.
`
`ISBSHOOXOO. First
`
`Goodsfservices
`Class Status -- ACTIVE.
`
`IC 009.
`
`US
`
`U21 U23 O26 O36 038.
`
`G & 8:
`
`liquids and solids: and electronic
`Apparatus for testing gas,
`apparatus for electrophysiological measurement and testing of cells;
`blank magnetic data carriers: computer software for use in data
`manipulation and instrument control for use in measuring the
`concentration of proteins, antibodies, antigens and other substances
`in body fluids for use in the diagnosis,
`treatment, prevention, cure
`and mitigation of diseases and other conditions in humans; and
`nephelometers for use in measuring the concentration of proteins,
`antibodies, antigens and other substances in body fluids for use in
`the diagnosis,
`treatment, prevention, cure and mitigation of diseases
`and other conditions in humans; electronic and computerized radial
`immunodiffusion plate readers; electrophoresis tank and power supply,
`for laboratory use: gel presses for pressing and drying gels:
`laboratory eguipment, namely,
`incubators. First Use: 1989/OOXOO.
`First Use In Commerce:
`IBBBIOOHOO.
`
`Prior Registration(s)
`l5OB8Bl;2U3l446;2053840;AND OTHERS
`
`I‘!
`Description of Mark
`_he mark consists of two hands black, holding a yellow globe; enclosed
`in the globe in black are stylized maps of the United Kingdom and
`Ireland;
`a rectangular base is featured below the hands;
`the body of
`the base is in yellow with a black outline, and the base features the
`black wording "THE BINDING SITE":
`the entire mark is surrounded by a
`narrow white boarder and a thin black line.
`
`Colors Claimed
`
`The color[s] Black, white and yellow is/are claimed as a feature of
`the mark.
`
`Filing Date
`2oo7x11x1s
`
`Examining Attorney
`BAKER,
`JORDAN
`
`Attorney of Record
`Jay H. Geller
`
`

`

`THE
`: BINDING
`1
`SITE __
`
`

`

`Pfini:Sep19,2fl14
`
`77437539
`
`DESIGN MARK
`
`Serial Number
`TT43T539
`
`Status
`REGISTERED
`
`Word Mark
`PANA—ME D
`
`Standard Character Merit
`No
`
`Registration Number
`3527240
`
`Date Registered
`2DDSx11xD4
`
`Type of Marin
`TRADEMARK
`
`Register
`PRINCIPAL
`
`Mark Drawing Code
`[3] DESIGN PLUS wcRDS, LETTERS ANDxcR NDNEERS
`
`Dvmer
`International Biomedical Inc. CORPORATION FLORIDA Suite 408 601 North
`
`Congress Avenue Delray Beach FLORIDA 33445
`
`Goodsfserviees
`Class Status -- ACTIVE.
`wheelchairs. First Use:
`I998/O4HO4.
`
`Goodsiservices
`Class Status —— ACTIVE.
`
`U19 U21 U23 U31 U35 U44.
`US
`IC 012.
`l998HO4fO4. First Use In Commerce:
`
`G & S:
`
`_
`
`.
`
`US
`
`O42 050.
`
`G & S: bedsheets.
`
`First Use:
`
`l998fU4fU4. First Use In Commerce:
`
`l998HU4fU4.
`
`Goodsiserviees
`laboratory
`G & S:
`U22 039.
`US
`_C 025.
`Class Status -- ACT_VE.
`coats. First Use: 1998fO4fO4. First Use In Commerce: 1998fO4fO4.
`
`Geedsfsewices
`Class Status -- ACTIVE.
`
`IC 005.
`
`US
`
`006 Ol8 O44 O46 O51 052.
`
`G & S:
`
`Pharmaceuticals for humans, namely, preparations for treatment o:
`allergic disorders, preparations for treatment of cardiovascular
`system conditions, preparations for treatment of central nervous
`
`.1.
`
`

`

`Pfini:Sep19,2fl14
`
`77437539
`
`system conditions, preparations for treatment of dermatological
`disorders, preparations for treatment of ear, nose and eye disorders,
`preparations for treatment of gastrointestinal disorders, preparations
`for treatment of immune system disorders, preparations for treatment
`of infections and infestations, preparations for treatment of
`musculoskeletal disorders, preparations for treatment of obstetric and
`gynecological disorders, preparations for treatment of poisoning and
`drug dependence, preparations for treatment of respiratory tract
`disorders, preparations for treatment of urinary system disorders,
`preparations for treatment of endocrine system disorders, preparations
`for cessation of smoking, analgesic medication for treatment of pain
`and pyrexia,
`topical and systemic anesthetic preparations, medicated
`creams and lotions for the skin, medicated creams and lotions for the
`hair, X-ray contrast media agents for medical or clinical use,
`laboratory reagents for medical or clinical use,
`In vitro test reagent
`strips for medical or clinical use for monitoring diabetes and blood
`chemistry,
`laxatives, antacids, chemotherapy agents, radiation therapy
`agents, vitamin and mineral supplements, nutritional supplements,
`appetite stimulants, appetite suppressants, electrolyte replacement
`supplements; all purpose disinfectants and deodorizers; pharmaceutical
`preparations for animals, namely, veterinary antibiotics for horses,
`sheep, pigs, cows, and poultry, veterinary antitussives and
`expectorants for horses, pigs, poultry, calves and cattle, veterinary
`analgesics and antipyretics for cattle, horses, pigs, sheep, dogs, and
`cats, mineral and vitamin supplements for cattle, sheep, swine, dogs,
`goats, horses, pigs, and poultry, veterinary disinfectants for water,
`eggs, udder teats, chicken pens, and cattle pens, vaccines infections
`and bronchitis, vaccines against egg drop syndrome in chickens,
`vaccines against hog cholera, vaccines against blackleg in cattle,
`sheep, and goats, vaccines against parvovirus infection in dogs, and
`vaccines against rabies. First Use:
`l998fO4/O4. First Use In
`Commerce:
`l998fO4fO4.
`
`Gaadslsenrices
`Class Status —— ACTIVE.
`
`:c 009.
`
`US
`
`021 023 025 035 038.
`
`e & a:
`
`Laboratory incubators. First Use: 1998fO4fO4. First Use In Commerce:
`l998fO4f04.
`
`Goodsfservices
`Class Status -- ACTIVE.
`
`IC 010.
`
`US
`
`O26 O39 044.
`
`G & 5: Blood
`
`pressure and heart monitors, namely, EKG machines, stethoscopes,
`sphygmomanometers, pulse oximeters, and saturation monitors;
`orthopaedic goods, namely, abdominal belts, wrist braces,
`acromioclavicular braces, ankle supports, post—operation shoes, arm
`slings, shoulder immobilizers, cast boots